WHO ICTRP trial

Artificial intelligence for pathological grading system of ganglion cells for…

ChiCTR2000035860 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2000035860
Public title Artificial intelligence for pathological grading system of ganglion cells for intraoperative rapid biopsy in Hirschsprung disease
Scientific title Artificial intelligence for pathological grading system of ganglion cells for intraoperative rapid biopsy in Hirschsprung disease
Primary sponsor Xinhua Hospital, Shanghai Jiaotong University School of Medicine
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Diagnostic test
Phase 0
Countries China
Conditions Hirschsprung disease
Interventions Gold Standard:The speciemens and sections will be reveiwed by three senior pediatric gastroenterology pathologists under the novel pathological grading system of ganglion cells in Hirschsprung disease, and the results is regarded as the…
Registration date Aug 18, 2020
Target size Target condition:138;Difficult condition:138
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations